Loading
A phase 1/2 trial of IBI343, capecitabine and cAPOX (capecitabine, oxaliplatin) in pancreatic cancer, run by Zhejiang Cancer Hospital, now recruiting.
IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer is a phase 1/2, interventional study registered as NCT07692750 by Zhejiang Cancer Hospital, with a registry enrolment figure of 56 participants, started 2025-04-30 and due to reach its primary completion in 2027-06-30. Interventions recorded: IBI343+ capecitabine; IBI343+Capecitabine+oxaliplatin. Conditions listed: Advanced Pancreatic Cancer. Primary outcome: Objective Response Rate (ORR) according to RECIST v1.1; Adverse Event, Treatment-Emergent Adverse Event, Adverse Event of Special Interest, Serious Serious Adverse EventChanges in laboratory tests, physical examinations, vital signs, etc., incidence, and correlation with experimental drugs. Sites: China. No results are recorded here; the registry entry is the source.
Shares IBI343, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Antibody-drug conjugate (ADC) and the tag pancreatic-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Capecitabine, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares IBI343, Pancreatic cancer trials open today (registry snapshot and UK sites), Antibody-drug conjugate (ADC) and the tag pancreatic-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares Capecitabine, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.